Garefis Konstantinos, Chatziavramidis Angelos, Goulis Dimitrios, Nikolaidis Vasileios, Markou Konstantinos, Konstantinidis Iordanis
2nd Academic ORL, Head and Neck Surgery Department, Aristotle University of Thessaloniki, Papageorgiou Hospital, Thessaloniki, Greece.
Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Eur Arch Otorhinolaryngol. 2025 Sep 23. doi: 10.1007/s00405-025-09678-1.
To assess the safety of methylprednisolone irrigation in the ductal system of salivary glands during sialendoscopy and its impact on the hypothalamic-pituitary-adrenal (HPA) axis.
Nineteen patients with non-lithiasic sialadenitis were included. Sialendoscopy was performed on the most affected gland (11 parotid, 8 submandibular glands), with 60 mg of methylprednisolone in a 5 ml solution of 0.9% NaCl saline irrigated into the ductal system. Serum cortisol and methylprednisolone concentrations were measured before irrigation, at 2 and 24 h (h) post-irrigation. Patients were examined for post-interventional symptoms and signs 24 h later.
Serum cortisol concentrations increased at 2 h (p < 0.05), followed by a decrease (p < 0.01) at 24 h. Decrease was recorded in serum cortisol from 0 h to 24 h (17.2 ± 5.9 vs. 9.2 ± 8.0 µg/dl, respectively, p < 0.01); 37% of patients fulfilled the criteria for HPA axis suppression (serum cortisol ≤ 1.8 µg/dl). A similar pattern for serum cortisol was observed for the parotid and submandibular glands separately, with more pronounced decrease in the parotid. Serum methylprednisolone increased at 2 h, followed by a decrease to minimal concentrations at 24 h. Pain during methylprednisolone irrigation was reported in 57.9% of patients. Blood pressure and glucose concentrations remained unaffected, and no other symptoms were reported.
Methylprednisolone irrigation during sialendoscopy caused biochemical HPA axis suppression in 37% of patients after 24 h. However, the procedure is considered safe, as there were no reported cases of clinical hypocortisolemia. The decrease in serum cortisol at 24 h was observed mainly after parotid gland irrigation. Minimal drug concentrations were found in the serum after 24 h.
评估涎腺内镜检查时在涎腺导管系统中灌注甲泼尼龙的安全性及其对下丘脑-垂体-肾上腺(HPA)轴的影响。
纳入19例非结石性涎腺炎患者。对受累最严重的腺体(11例腮腺、8例颌下腺)进行涎腺内镜检查,将60mg甲泼尼龙溶于5ml 0.9%氯化钠盐溶液中灌注到导管系统。在灌注前、灌注后2小时和24小时测量血清皮质醇和甲泼尼龙浓度。24小时后检查患者的介入后症状和体征。
血清皮质醇浓度在2小时时升高(p<0.05),随后在24小时时下降(p<0.01)。从0小时到24小时血清皮质醇下降(分别为17.2±5.9 vs. 9.2±8.0μg/dl,p<0.01);37%的患者符合HPA轴抑制标准(血清皮质醇≤1.8μg/dl)。腮腺和颌下腺分别观察到血清皮质醇的类似模式,腮腺下降更明显。血清甲泼尼龙在2小时时升高,随后在24小时时降至最低浓度。57.9%的患者报告了甲泼尼龙灌注期间的疼痛。血压和血糖浓度未受影响,未报告其他症状。
涎腺内镜检查时灌注甲泼尼龙在24小时后导致37%的患者出现生化性HPA轴抑制。然而,该操作被认为是安全的,因为没有临床肾上腺皮质功能减退的报告病例。24小时时血清皮质醇的下降主要在腮腺灌注后观察到。24小时后血清中发现的药物浓度最低。